Response to once-monthly and daily oral ibandronate in women with postmenopausal osteoporosis: 2-year findings from mobile

被引：0
|
作者：
Stepan, J. J.
Kendler, D.
Sedarati, F.
Burdeska, A.
Hughes, C.
Lorenc, R.
机构：
[1] Univ Prague, Prague, Czech Republic
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] Childrens Mem Inst, Warsaw, Poland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [31] Monthly oral ibandronate is at least as effective as oral daily ibandronate in postmenopausal osteoporosis: 1-Year results from MOBILE.
    Miller, PD
    Drezner, HK
    Delmas, PD
    Stakkestad, JA
    Hughes, C
    Bonvoisin, B
    Reginster, JY
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S94 - S94
  • [32] Once-monthly oral ibandronate versus weekly oral alendronate in postmenopausal osteoporosis: Rationale and design of motion
    Epstein, S.
    Borges, J. L. C.
    Mautalen, C.
    Gonzalez Macias, J.
    Mahoney, P.
    El Azzouzi, B.
    Masanauskaite, D.
    Cosman, F.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S252 - S252
  • [33] Once-monthly ibandronate for postmenopausal osteoporosis: Review of a new dosing regimen
    Pyon, Eunice Y.
    CLINICAL THERAPEUTICS, 2006, 28 (04) : 475 - 490
  • [34] Patient preference for once-monthly oral ibandronate and weekly oral alendronate in postmenopausal osteoporosis: The BALTO II study
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S127 - S128
  • [35] The BALTO II study: Patient preference for once-monthly oral ibandronate and weekly oral alendronate in postmenopausal osteoporosis
    Minne, H.
    Bourgeois, P.
    Devas, V.
    Masanauskaite, D.
    Minic, B.
    Licata, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 423 - 423
  • [36] Monthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis: 1-year results from mobile
    Cooper, C
    Stepan, JJ
    Lorenc, R
    Hughes, C
    Mairon, N
    Sedarati, F
    Reginster, JY
    BONE, 2005, 36 : S417 - S417
  • [37] Once-monthly ibandronate dosing is more effective than daily dosing for improving bone mineral density: Mobile 2-year analysis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S160 - S161
  • [38] Hip Structural Analysis Based on DXA Data in Women with Postmenopausal Osteoporosis Receiving Once-Monthly Oral Ibandronate for 12 Months
    Lewieeki, E. M.
    Genant, H. K.
    Engelke, K.
    Fuerst, F.
    Fries, M.
    Enslin, M.
    Fitzpatrick, L. A.
    Kivitz, A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S229 - S229
  • [39] A candidate-identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate
    Kutsal, Y. Gokce
    Eskiyurt, N.
    Irdesel, J.
    Sepici, V.
    Ugurlu, H.
    Kirazli, Y.
    Ardic, F.
    Korsic, M.
    Vlak, T.
    Grlickov, M.
    Temelkova, S. M.
    Lazarov, M.
    Pilipovic, N.
    Popovic, V.
    Dimic, A.
    Kovacev, B.
    Ruci, D.
    Tafaj, A.
    Kucukalic-Selimovic, E.
    Avdic, D.
    Seleskovic, H.
    Pejicic, S.
    Butun, B.
    Akyuz, G.
    Cerrahoglu, L.
    Sendur, O. F.
    Yalcin, P.
    Oncel, S.
    Saridogan, M.
    Sarpel, T.
    Tosun, M.
    Senel, K.
    Gursoy, S.
    Canturk, F.
    Demir, H.
    Miskic, B.
    Krpan, D.
    Skreb, F.
    Grazio, S.
    Crncevic-Orlic, Z.
    Ozdener, F.
    Oncel, H.
    BONE, 2011, 48 : S233 - S234
  • [40] Monthly oral ibandronate is well tolerated in women with postmenopausal osteoporosis: 1-year results from MOBILE.
    Lewiecki, EM
    Miller, PD
    Lorenc, R
    Hughes, C
    Bonvoisin, B
    McClung, MR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S446 - S446
12345